Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Treatment With Canagliflozin Versus Placebo in Children and Adolescents With Type 2 Diabetes : A Randomized Clinical Trial.
Journal: Annals of internal medicine
Published: August 04, 2025
Natriuretic Peptides and Prognosis in Patients With Type 2 Diabetes Mellitus and High Risk for Cardiovascular Events.
Journal: Journal of cardiac failure
Published: September 27, 2023
Association Between Circulating GDF-15 and Cardio-Renal Outcomes and Effect of Canagliflozin: Results From the CANVAS Trial.
Journal: Journal of the American Heart Association
Published: December 02, 2021
Fasting Substrate Concentrations Predict Cardiovascular Outcomes in the CANagliflozin cardioVascular Assessment Study (CANVAS).
Journal: Diabetes care
Published: November 17, 2021
Stress Cardiac Biomarkers, Cardiovascular and Renal Outcomes, and Response to Canagliflozin.
Journal: Journal of the American College of Cardiology
Published: April 16, 2021
Effects of canagliflozin on myocardial infarction: a post hoc analysis of the CANVAS programme and CREDENCE trial.
Journal: Cardiovascular research
Published: September 15, 2020
Insulin-Like Growth Factor Binding Protein 7 Predicts Renal and Cardiovascular Outcomes in the Canagliflozin Cardiovascular Assessment Study.
Journal: Diabetes care
Published: July 28, 2020
Effects of Canagliflozin on Amino-Terminal Pro-B-Type Natriuretic Peptide: Implications for Cardiovascular Risk Reduction.
Journal: Journal of the American College of Cardiology
Published: July 22, 2020
The effects of combination canagliflozin and glucagon-like peptide-1 receptor agonist therapy on intermediate markers of cardiovascular risk in the CANVAS program.
Journal: International journal of cardiology
Published: March 19, 2020
Clinical outcomes with canagliflozin according to baseline body mass index: results from post hoc analyses of the CANVAS Program.
Journal: Diabetes, obesity & metabolism
Published: July 12, 2019
Mediators of the Effects of Canagliflozin on Heart Failure in Patients With Type 2 Diabetes.
Journal: JACC. Heart failure
Published: May 01, 2019
Effects of Canagliflozin on Heart Failure Outcomes Associated With Preserved and Reduced Ejection Fraction in Type 2 Diabetes Mellitus.
Journal: Circulation
Published: March 19, 2019
Last Updated: 09/26/2026